BioSpace News Archive

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that results from the US Phase 3

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer

Common shares will be consolidated on the Nasdaq exchange where shareholders can continue trading under the symbol “PRTG”

St. Luke’s is pleased to introduce its new COVID Recovery Clinic, a program dedicated to the treatment of post-COVID-19 patients with lingering symptoms.

Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1

Seigla Medical, Inc., announced conformité européenne (CE) Mark for the company’s LiquID™ Guide Catheter Extension for use in coronary and peripheral vasculature interventions. Guide catheter extensions are a crucial tool used by cardiologists worldwide to assist in the delivery of stents and other interventional devices.

Immunovia’s bloodtest IMMray™ PanCan-d was mentioned in the seminar “The latest in early detection for pancreatic cancer” arranged by Pancreatic Cancer Action Network (pancan.org) on April 15, 2021.

The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). Date April 16, 2021 Time 11:45 AM (EDT) Location Sir John A Macdonald Building, Room 200 144 Wellington Street, Ottawa, Ontario

RaySearch Laboratories AB (publ) announces that the new carbon ion therapy center at Yamagata University Hospital in Northern Japan , has treated its first patients using the RayStation®* treatment planning system in combination with Toshiba’s treatment delivery system.

SecuSeal™ digital health card provides immediate, more secure proof of vaccination status while protecting privacy.